PAMU
KYNB

Pictet Asset Management (UK)’s Kyntra Bio KYNB Stock Holding History

Pictet Asset Management (UK)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$2.66M Buy
3,992
+3,728
+1,412% +$2.15M ﹤0.01% 966
2021
Q1 		$229K Hold
264
– – ﹤0.01% 1598
2020
Q4 		$245K Hold
264
– – ﹤0.01% 1504
2020
Q3 		$271K Buy
+264
New +$284K ﹤0.01% 1276

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management (UK)'s KYNB Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Kyntra Bio (KYNB) stake by 1,412% in Q2 2021, buying an estimated $2.15M and bringing the position to 3,992 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Pictet Asset Management (UK) first reported a position in KYNB in Q3 2020 and has held it in 4 quarters since. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Pictet Asset Management (UK) held 3,992 shares of Kyntra Bio worth $2.66M as of Q2 2021.
  • Pictet Asset Management (UK) bought 3,728 Kyntra Bio shares in Q2 2021, an estimated $2.15M.
  • Kyntra Bio made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #966 holding.
  • Pictet Asset Management (UK) first reported a position in Kyntra Bio in Q3 2020 and has held it in 4 quarters since.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.